Sphingosine suppresses mesothelioma cell proliferation by inhibiting PKC-δ and inducing cell cycle arrest at the G 0 /G 1 phase

Cellular Physiology and Biochemistry

Volumn 30, Issue 4, 2012, Pages 995-1004

  Okuwa, Hisaya ^a   Kanno, Takeshi ^a   Fujita, Yumiko ^a   Gotoh, Akinobu ^a   Tabata, Chiharu ^a   Fukuoka, Kazuya ^a   Nakano, Takashi ^a   Nishizaki, Tomoyuki ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Mesothelioma cell; Proliferation; Protein kinase C ; Sphingosine; Suppression

Indexed keywords

PROTEIN KINASE C DELTA; ROTTLERIN; SMALL INTERFERING RNA; SPHINGOSINE;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL FREE SYSTEM; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; FLOW CYTOMETRY; GENE CONSTRUCT; GENE SILENCING; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MALIGNANT MESOTHELIOMA; PRIORITY JOURNAL;

EID: 84870374951     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000341476     Document Type: Article

References (35)

1. Kanno T, Nishizaki T: Sphingosine induces apoptosis in hippocampal neurons and astrocytes by activating caspase-3/-9 via a mitochondrial pathway linked to SDK/14-3-3 protein/Bax/cytochrome c. J Cell Physiol 2011;226:2329-2337.
2. Suzuki E, Handa K, Toledo MS, Hakomori S: Sphingosine-dependent apoptosis: a unified concept based on multiple mechanisms operating in concert. Proc Natl Acad Sci USA 2004;101:14788-14793. (Pubitemid 39410753)
3. Hamaguchi A, Suzuki E, Murayama K, Fujimura T, Hikita T, Iwabuchi K, Handa K, Withers DA, Masters SC, Fu H, Hakomori S: A sphingosine-dependent protein kinase that specifically phosphorylates 14-3-3 (SDK1) is identified as the kinase domain of PKC8: a preliminary note. Biochem Biophys Res Commun 2003;307:589-594. (Pubitemid 36944973)
4. Hamaguchi A, Suzuki E, Murayama K, Fujimura T, Hikita T, Iwabuchi K, Handa K, Withers DA, Masters SC, Fu H, Hakomori S: Sphingosine-dependent protein kinase-1, directed to 14-3-3, is identified as the kinase domain of protein kinase CS. J Biol Chem 2003;278:41557-41565. (Pubitemid 37280986)
5. Phillips DC, Martin S, Doyle BT, Houghton JA: Sphingosine-induced apoptosis in rhabdomyosarcoma cell lines is dependent on pre-mitochondrial Bax activation and post-mitochondrial caspases. Cancer Res 2007;67:756-764. (Pubitemid 46192216)
6. Shimizu T, Kanno T, Tanaka A, Nishizaki T: a, f3-DCP-LA selectively activates PKC-s and stimulates neurotransmitter release with the highest potency among 4 diastereomers. Cell Physiol Biochem 2011;27:149-158.
7. Nishizuka Y: Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 1992;258:607-614.
8. Nishizuka Y: Protein kinase C and lipid signaling for sustained cellular responses. FASEB J 1995;9:484-496.
9. Steinberg SF: Distinctive activation mechanisms and functions for protein kinase CS. Biochem J 2004;384:449-459. (Pubitemid 40018958)
10. Hannun YA, Loomis CR, Merrill AH Jr, Bell RM: Sphingosine inhibition of protein kinase C activity and of phorbol dibutyrate binding in vitro and in human platelets. J Biol Chem 1986;261:12604-12609. (Pubitemid 17213985)
11. El Touny S, Khan W, Hannun Y: Regulation of platelet protein kinase C by oleic acid. Kinetic analysis of allosteric regulation and effects on autophosphorylation, phorbol ester binding, and susceptibility to inhibition. J Biol Chem 1990;265:16437-16443.
12. Merrill AH Jr, Sereni AM, Stevens VL, Hannun YA, Bell RM, Kinkade JM Jr: Inhibition of phorbol esterdependent differentiation of human promyelocytic leukemic (HL-60) cells by sphinganine and other longchain bases. J Biol Chem 1986;261:12610-12615. (Pubitemid 17204214)
13. Merrill AH Jr, Nimkar S, Menaldino D, Hannun YA, Loomis C, Bell RM, Tyagi SR, Lambeth JD, Stevens VL, Hunter R, Liotta DC: Structural requirements for long-chain (sphingoid) base inhibition of protein kinase C in vitro and for the cellular effects of these compounds. Biochemistry 1989;28:3138-3145. (Pubitemid 19121904)
14. Bazzi MD, Nelsestuen GL: Mechanism of protein kinase C inhibition by sphingosine. Biochem Biophys Res Commun 1987;146:203-207.
15. Smith ER, Jones PL, Boss JM, Merrill AH Jr: Changing J774A.1 cells to new medium perturbs multiple signaling pathways, including the modulation of protein kinase C by endogenous sphingoid bases. J Biol Chem 1997;272:5640-5646. (Pubitemid 27102391)
16. Nakamura T, Abe A, Balazovich KJ, Wu D, Suchard SJ, Boxer LA, Shayman JA: Ceramide regulates oxidant release in adherenthuman neutrophils. J Biol Chem 1994;269:18384-18389. (Pubitemid 24224067)
17. Merrill AH Jr, Hannun YA, Bell RM: Introduction: Sphingolipids and their metabolites in cell regulation. Adv Lipid Res 1993;25:1-24.
18. Raeder EM, Mansfield PJ, Hinkovska-Galcheva V, Kjeldsen L, Shayman JA, Boxer LA: Sphingosine blocks human polymorphonuclear leukocyte phagocytosis through inhibition of mitogen-activated protein kinase activation. Blood 1999;93:686-693. (Pubitemid 29035751)
19. Basu A, Pal D: Two faces of protein kinase CS: the contrasting roles of PKCS in cell survival and cell death. ScientificWorldJournal 2010;10:2272-2284.
20. Okhrimenko H, Lu W, Xiang C, Ju D, Blumberg PM, Gomel R, Kazimirsky G, Brodie C: Roles of tyrosine phosphorylation and cleavage of protein kinase CS in its protective effect against tumor necrosis factorrelated apoptosis inducing ligand-induced apoptosis. J Biol Chem 2005;280:23643-23652. (Pubitemid 40884845)
21. Lu W, Lee HK, Xiang C, Finniss S, Brodie C: The phosphorylation of tyrosine 332 is necessary for the caspase 3-dependent cleavage of PKCδand the regulation of cell apoptosis. Cell Signal 2007;19:2165-2173. (Pubitemid 47353819)
22. Grossoni VC, Falbo KB, Kazanietz MG, De Kier Joffe ED, Urtreger AJ: Protein kinase CS enhances proliferation and survival of murine mammary cells. Mol Carcinog 2007;46:381-390. (Pubitemid 46744458)
23. McCracken MA, Miraglia LJ, McKay RA, Strobl JS: Protein kinase CS is a prosurvival factor in human breast tumor cell lines. Mol Cancer Ther 2003;2:273-281.
24. Clark AS, West KA, Blumberg PM, Dennis PA: Altered protein kinase C (PKC) isoforms in non-small cell lung cancer cells: PKC8 promotes cellular survival and chemotherapeutic resistance. Cancer Res 2003;63:780-786. (Pubitemid 36231976)
25. Basu A, Miura A: Differential regulation of extrinsic and intrinsic cell death pathways by protein kinase C. Int J Mol Med 2002;10:541-545.
26. Wang Q, Wang X, Evers BM: Induction of cIAP-2 in human colon cancer cells through PKC delta/NF-KB. J Biol Chem 2003;278:51091-51099. (Pubitemid 38020344)
27. Wang Q, Wang X, Zhou Y, Evers BM: PKCS-mediated regulation of FLIP expression in human colon cancer cells. Int J Cancer 2006;118:326-334 (Pubitemid 41779071)
28. Mann AP, Verma A, Sethi G, Manavathi B, Wang H, Fok JY, Kunnumakkara AB, Kumar R, Aggarwal BB, Mehta K: Overexpression of tissue transglutaminase leads to constitutive activation of nuclear factor-KB in cancer cells: delineation of a novel pathway. Cancer Res 2006;66:8788-8795. (Pubitemid 44449196)
29. Lu ZG, Liu H, Yamaguchi T, Miki Y, Yoshida K: Protein kinase CS activates RelA/p65 and nuclear factor-KB signaling in response to tumor necrosis factor-α. Cancer Res 2009;69:5927-5935.
30. Zhang J, Liu N, Liu S, Liu Y, Zheng D: PKCS protects human breast tumor MCF-7 cells against tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis. J Cell Biochem 2005;96:522-532. (Pubitemid 41504650)
31. Xia S, Chen Z, Forman LW, Faller DV: PKCS survival signaling in cells containing an activated p21Ras protein requires PDK1. Cell Signal 2009;21:502-508.
32. Mauro LV, Grossoni VC, Urtreger AJ, Yang C, Colombo LL, Morandi A, Pallotta MG, Kazanietz MG, Bal De Kier Joffe ED, Puricelli LL: PKC Delta (PKCS) promotes tumoral progression of human ductal pancreatic cancer. Pancreas 2010;39:e31-41.
33. Lonne GK, Masoumi KC, Lennartsson J, Larsson C: Protein kinase CS supports survival of MDA-MB-231 breast cancer cells by suppressing the ERK1/2 pathway. J Biol Chem 2009;284:33456-33465.
34. Quadros MR, Connelly S, Kari C, Abrams MT, Wickstrom E, Rodeck U: EGFR-dependent downregulation of Bim in epithelial cells requires MAPK and PKC-S activities. Cancer Biol Ther 2006;5:498-504. (Pubitemid 43765284)
35. Baudot AD, Jeandel PY, Mouska X, Maurer U, Tartare-Deckert S, Raynaud SD, Cassuto JP, Ticchioni M, Deckert M: The tyrosine kinase Syk regulates the survival of chronic lymphocytic leukemia B cells through PKCS and proteasome-dependent regulation of Mcl-1 expression. Oncogene 2009;28:3261-3273.